By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Pivotal Therapeutics Inc.  

3701 FAU Blvd, Building 3, Suite 210

Boca Raton  Florida   33431  U.S.A.
Phone: 561-288-5231 Fax: n/a


SEARCH JOBS


Industry
Pharmaceutical






Company News
Pivotal Therapeutics Inc. Announces Payment Of Interest On Outstanding Convertible Notes 3/26/2015 9:42:49 AM
Pivotal Therapeutics Inc. Announces The Issuance Of Two Patents Both Related To The Combination Of VASCAZEN® With Key Cholesterol Lowering Agents (Statins) And Cholesterol Absorption Inhibitors 2/10/2015 11:32:58 AM
Pivotal Therapeutics Inc. Receives Final Approval For Phase 2a Clinical Trial With PVT-100 1/27/2015 11:39:26 AM
Pivotal Therapeutics Inc.: Year In Review And CEO Update 1/23/2015 10:45:05 AM
Pivotal Therapeutics Inc. Announces Payment Of Interest On Outstanding Convertible Notes 1/6/2015 7:20:40 AM
Pivotal Therapeutics Inc. Release: VASCAZEN POMEGA Phase 2a Trial Protocol Cleared Clinical Evaluation By French FDA 12/17/2014 8:49:35 AM
Pivotal Therapeutics Inc. Announces Third Quarter Accomplishments And Financial Results 12/1/2014 9:14:05 AM
Pivotal Therapeutics Inc. Announces Senior Management Change 11/17/2014 11:24:30 AM
Pivotal Therapeutics Inc. Receives Notification Of Allowance For U.S. Patent Related To Combination VASCAZEN® And Cholesterol Absorption Inhibitor 10/8/2014 11:28:44 AM
Pivotal Therapeutics Inc. Announces Notification Of Patent Allowance For U.S. Application 13/584,480 Related To Combination Product Of VASCAZEN® And Statin Therapy 10/7/2014 8:56:07 AM
123456
//-->